Los Angeles Capital Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
Other funds holding AVXL
SF
Los Angeles Capital Management's AVXL Position: Q2 2026 in Review
Los Angeles Capital Management increased its Anavex Life Sciences (AVXL) stake by 15,359% in Q2 2026, buying an estimated $285K and bringing the position to 96,925 shares worth $251K. The position accounts for ﹤0.01% of the portfolio, ranked #1104.
Los Angeles Capital Management first reported a position in AVXL in Q3 2022 and has held it in 8 quarters since. The position peaked at $541K in Q4 2023. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.
- Los Angeles Capital Management held 96,925 shares of Anavex Life Sciences worth $251K as of Q2 2026.
- Los Angeles Capital Management bought 96,298 Anavex Life Sciences shares in Q2 2026, an estimated $285K.
- Anavex Life Sciences made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1104 holding.
- Los Angeles Capital Management first reported a position in Anavex Life Sciences in Q3 2022 and has held it in 8 quarters since.
- Los Angeles Capital Management's Anavex Life Sciences position peaked at $541K in Q4 2023.
- 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.
Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.